<div id="readability-page-1"><p>Dolby Laboratories, Inc. (NYSE:DLB - Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 730,100 shares,  a drop of 9.3% from the January 15th total of 805,400 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average trading volume of 496,800 shares, the short-interest ratio is currently 1.5 days.</p><div><p><span></span><span>Get <strong>Dolby Laboratories</strong> alerts:</span></p></div><h2>Dolby Laboratories Price Performance</h2><ul><li>Big Screen Stock Soars on Blockbuster Q2 Earnings</li></ul><p>NYSE DLB traded down $0.56 during trading hours on Monday, reaching $83.72. 440,257 shares of the stock traded hands, compared to its average volume of 503,875. The stock has a 50 day simple moving average of $80.26 and a two-hundred day simple moving average of $76.06. Dolby Laboratories has a 1 year low of $66.35 and a 1 year high of $89.66. The company has a market cap of $7.99 billion, a price-to-earnings ratio of 30.78 and a beta of 0.98. </p><h2>Dolby Laboratories Announces Dividend</h2><p>The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th will be given a $0.33 dividend. The ex-dividend date of this dividend is Tuesday, February 11th. This represents a $1.32 dividend on an annualized basis and a yield of 1.58%. Dolby Laboratories's payout ratio is 48.53%. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several equities research analysts recently issued reports on the company. Rosenblatt Securities  reissued a &#34;buy&#34; rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Thursday, January 30th. StockNews.com downgraded Dolby Laboratories from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Friday, January 31st. Finally, Barrington Research  restated an &#34;outperform&#34; rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Thursday.</p><p><b>View Our Latest Analysis on Dolby Laboratories</b></p><h2>Insider Transactions at Dolby Laboratories</h2><p>In other news, CAO Ryan Nicholson sold 7,000 shares of the stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the sale, the chief accounting officer now directly owns 29,758 shares of the company's stock, valued at approximately $2,501,755.06. This represents a 19.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Mark Andrew Sherman sold 40,000 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the transaction, the executive vice president now directly owns 62,397 shares of the company's stock, valued at approximately $5,296,257.36. This represents a 39.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 182,917 shares of company stock valued at $14,861,429 over the last three months. Company insiders own  38.39% of the company's stock. </p><h2>Institutional Inflows and Outflows</h2><p>Institutional investors and hedge funds have recently bought and sold shares of the business. Fifth Third Bancorp boosted its stake in shares of  Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 163 shares in the last quarter.  Nisa Investment Advisors LLC boosted its position in  Dolby Laboratories by 436.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after buying an additional 301 shares during the period.  Mather Group LLC. grew its stake in shares of  Dolby Laboratories by 36.8% during the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after buying an additional 142 shares during the last quarter.  Headlands Technologies LLC purchased a new position in shares of  Dolby Laboratories in the fourth quarter worth about $57,000.  Finally, GAMMA Investing LLC boosted its holdings in  Dolby Laboratories by 207.5% during the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock valued at $61,000 after acquiring an additional 525 shares during the period. 58.56% of the stock is currently owned by institutional investors. </p><h2>Dolby Laboratories Company Profile</h2> (Get Free Report)<p>Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC &amp; HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Dolby Laboratories</li><li>Insider Trading - What You Need to Know</li><li>Airbnb's Earnings: Sky High Results, Grounded Guidance?</li><li>What is a Bond Market Holiday? How to Invest and Trade</li><li>Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?</li><li>Options Trading - Understanding  Strike Price</li><li>Conflicting Signals: Tempus AI's Stock Market Rally </li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Where Should You Invest $1,000 Right Now?</h2><p>Before you make your next trade, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p><p>They believe these five stocks are the five best companies for investors to buy now...</p><p>See The Five Stocks Here </p><h2>Should You Invest $1,000 in Dolby Laboratories Right Now?</h2><p>Before you consider Dolby Laboratories, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.</p><p>While Dolby Laboratories currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Dolby Laboratories, Inc. (NYSE:DLB) experienced a significant drop in short interest, falling 9.3% to 730,100 shares by January 31. The short-interest ratio is now 1.5 days, with 1.2% of shares sold short. The stock traded down to $83.72, with a market cap of $7.99 billion and a P/E ratio of 30.78. Dolby also announced a quarterly dividend of $0.33, payable on February 19. Analysts maintain a positive outlook, with price targets around $100. Recent insider sales totaled 182,917 shares valued at $14.86 million.</p>

Dolby Laboratories, Inc. (NYSE:DLB) Sees Significant Drop in Short Interest